Showing results (511-520 of 602) with videos related to
Sort By:
Pageof 61
Human Brain Mapping|August 21, 2014
Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up studyOmar F F Odish, Annette A van den Berg-Huysmans, Simon J A van den Bogaard, et al.Biological Psychiatry|November 28, 2017
Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic GenesPeter McColgan, Sarah Gregory, Kiran K Seunarine, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1Yi Wang, Olga Roche, Chaoying Xu, et al.Neuroimage. Clinical|July 24, 2018
Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up studyVerena Baake, Emma M Coppen, Erik van Duijn, et al.Frontiers in Oncology|August 16, 2021
Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical ProstatectomyPhilipp Mandel, Benedikt Hoeh, Felix Preisser, et al.Journal of Neurology|October 12, 2010
Early atrophy of pallidum and accumbens nucleus in Huntington's diseaseSimon J A van den Bogaard, Eve M Dumas, Tanka P Acharya, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2017
Design optimization for clinical trials in early-stage manifest Huntington's diseaseChris Frost, Amy Mulick, Rachael I Scahill, et al.Neuropsychologia|November 1, 2015
The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's DiseaseEileanoir B Johnson, Elin M Rees, Izelle Labuschagne, et al.Cancer Research|November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein doseA C van Hof, C F Molthoff, Q Davies, et al.Neuroimage. Clinical|November 2, 2013
Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON studyNicola Z Hobbs, James H Cole, Ruth E Farmer, et al.Pageof 61